nach oben

Reactions Weekly

Erschienen in:

01.07.2022 | Case report

CAR-T-cell-therapies/tocilizumab/unspecified steroids

Cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: 6 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Borogovac A, et al. Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center. Bone Marrow Transplantation 57: 1025-1027, No. 6, Jun 2022. Available from: URL: http://www.nature.com/bmt/index.html

Titel: CAR-T-cell-therapies/tocilizumab/unspecified steroids
Cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: 6 case reports
Publikationsdatum: 01.07.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-19144-6

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

CAR-T-cell-therapies/tocilizumab/unspecified steroids

Cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: 6 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Aripiprazole/haloperidol/promethazine

Enoxaparin-sodium

Multiple drugs

Convalescent-anti-SARS-COV-2-plasma

Ethinylestradiol

Atezolizumab